These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 15331068)
1. Lipid metabolism in hepatic steatosis. Bradbury MW; Berk PD Clin Liver Dis; 2004 Aug; 8(3):639-71, xi. PubMed ID: 15331068 [TBL] [Abstract][Full Text] [Related]
2. Increased hepatocellular uptake of long chain fatty acids occurs by different mechanisms in fatty livers due to obesity or excess ethanol use, contributing to development of steatohepatitis in both settings. Berk PD; Zhou S; Bradbury MW Trans Am Clin Climatol Assoc; 2005; 116():335-44; discussion 345. PubMed ID: 16555625 [TBL] [Abstract][Full Text] [Related]
3. Role of fatty acids in the pathogenesis of obesity and fatty liver: impact of bariatric surgery. Verna EC; Berk PD Semin Liver Dis; 2008 Nov; 28(4):407-26. PubMed ID: 18956297 [TBL] [Abstract][Full Text] [Related]
4. Long-chain fatty acid uptake is upregulated in omental adipocytes from patients undergoing bariatric surgery for obesity. Petrescu O; Fan X; Gentileschi P; Hossain S; Bradbury M; Gagner M; Berk PD Int J Obes (Lond); 2005 Feb; 29(2):196-203. PubMed ID: 15570311 [TBL] [Abstract][Full Text] [Related]
5. Nonalcoholic hepatic steatosis in Zucker diabetic rats: spontaneous evolution and effects of metformin and fenofibrate. Forcheron F; Abdallah P; Basset A; del Carmine P; Haffar G; Beylot M Obesity (Silver Spring); 2009 Jul; 17(7):1381-9. PubMed ID: 19553925 [TBL] [Abstract][Full Text] [Related]
6. Lipid metabolism and liver inflammation. I. Hepatic fatty acid uptake: possible role in steatosis. Bradbury MW Am J Physiol Gastrointest Liver Physiol; 2006 Feb; 290(2):G194-8. PubMed ID: 16407588 [TBL] [Abstract][Full Text] [Related]
7. Hepatic steatosis: a mediator of the metabolic syndrome. Lessons from animal models. den Boer M; Voshol PJ; Kuipers F; Havekes LM; Romijn JA Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):644-9. PubMed ID: 14715643 [TBL] [Abstract][Full Text] [Related]
8. The significance of differences in fatty acid metabolism between obese and non-obese patients with non-alcoholic fatty liver disease. Nakamuta M; Kohjima M; Higuchi N; Kato M; Kotoh K; Yoshimoto T; Yada M; Yada R; Takemoto R; Fukuizumi K; Harada N; Taketomi A; Maehara Y; Nakashima M; Enjoji M Int J Mol Med; 2008 Nov; 22(5):663-7. PubMed ID: 18949388 [TBL] [Abstract][Full Text] [Related]
9. Phosphatidylinositol 3-kinase-dependent insulin regulation of long-chain fatty acid (LCFA) metabolism in L6 muscle cells: involvement of atypical protein kinase C-zeta in LCFA uptake but not oxidation. Kelly KR; Sung CK; Abbott MJ; Turcotte LP J Endocrinol; 2008 Aug; 198(2):375-84. PubMed ID: 18480382 [TBL] [Abstract][Full Text] [Related]
10. Modulation of the hepatic malonyl-CoA-carnitine palmitoyltransferase 1A partnership creates a metabolic switch allowing oxidation of de novo fatty acids. Akkaoui M; Cohen I; Esnous C; Lenoir V; Sournac M; Girard J; Prip-Buus C Biochem J; 2009 May; 420(3):429-38. PubMed ID: 19302064 [TBL] [Abstract][Full Text] [Related]
11. Serotonin mediates oxidative stress and mitochondrial toxicity in a murine model of nonalcoholic steatohepatitis. Nocito A; Dahm F; Jochum W; Jang JH; Georgiev P; Bader M; Renner EL; Clavien PA Gastroenterology; 2007 Aug; 133(2):608-18. PubMed ID: 17681180 [TBL] [Abstract][Full Text] [Related]
13. Dietary single cell protein reduces fatty liver in obese Zucker rats. Gudbrandsen OA; Wergedahl H; Liaset B; Espe M; Mørk S; Berge RK Br J Nutr; 2008 Oct; 100(4):776-85. PubMed ID: 18346305 [TBL] [Abstract][Full Text] [Related]
14. Insulin- and leptin-regulated fatty acid uptake plays a key causal role in hepatic steatosis in mice with intact leptin signaling but not in ob/ob or db/db mice. Ge F; Zhou S; Hu C; Lobdell H; Berk PD Am J Physiol Gastrointest Liver Physiol; 2010 Oct; 299(4):G855-66. PubMed ID: 20595619 [TBL] [Abstract][Full Text] [Related]
15. Enhanced sarcolemmal FAT/CD36 content and triacylglycerol storage in cardiac myocytes from obese zucker rats. Coort SL; Hasselbaink DM; Koonen DP; Willems J; Coumans WA; Chabowski A; van der Vusse GJ; Bonen A; Glatz JF; Luiken JJ Diabetes; 2004 Jul; 53(7):1655-63. PubMed ID: 15220187 [TBL] [Abstract][Full Text] [Related]
16. The establishment of a novel non-alcoholic steatohepatitis model accompanied with obesity and insulin resistance in mice. Cong WN; Tao RY; Tian JY; Liu GT; Ye F Life Sci; 2008 May; 82(19-20):983-90. PubMed ID: 18417155 [TBL] [Abstract][Full Text] [Related]
17. Etomoxir-induced partial carnitine palmitoyltransferase-I (CPT-I) inhibition in vivo does not alter cardiac long-chain fatty acid uptake and oxidation rates. Luiken JJ; Niessen HE; Coort SL; Hoebers N; Coumans WA; Schwenk RW; Bonen A; Glatz JF Biochem J; 2009 Apr; 419(2):447-55. PubMed ID: 19138173 [TBL] [Abstract][Full Text] [Related]
18. A new model for nonalcoholic steatohepatitis in the rat utilizing total enteral nutrition to overfeed a high-polyunsaturated fat diet. Baumgardner JN; Shankar K; Hennings L; Badger TM; Ronis MJ Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G27-38. PubMed ID: 17947452 [TBL] [Abstract][Full Text] [Related]
19. Medium-chain fatty acids ameliorate insulin resistance caused by high-fat diets in rats. Wein S; Wolffram S; Schrezenmeir J; Gasperiková D; Klimes I; Seböková E Diabetes Metab Res Rev; 2009 Feb; 25(2):185-94. PubMed ID: 19219861 [TBL] [Abstract][Full Text] [Related]